Want to see GB:ANIC full AI Analyst Report?
Agronomics (ANIC) AI Stock Analysis
Top Page
Agronomics
(LSE:ANIC)
The score is weighed down primarily by weak financial performance (recent losses and persistently negative cash flow), with technicals also bearish (price below key moving averages and negative MACD). Valuation is additionally constrained by a negative P/E driven by losses and no dividend data to offset risk; the main positive is the debt-free balance sheet, though equity has been eroding.
Agronomics (ANIC) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 47.13M
- Dividend Yield
- ―
- Average Volume (3M)
- 1.54M
- Price to Earnings (P/E)
- -2.7
- Beta (1Y)
- 1.41
- Revenue Growth
- ―
- EPS Growth
- 5.88%
- Country
- UK
- Employees
- 0
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Asset Management
Agronomics Business Overview & Revenue Model
Company Description
Agronomics Limited functions as a dedicated investment firm, primarily allocating capital across various financial instruments, including funds, equities, and equity-linked products. Its portfolio spans both publicly traded and privately held compani...
How the Company Makes Money
Agronomics primarily makes money through investment returns on its portfolio rather than operating revenue from selling goods or services. Its key economic drivers are: (1) Realised gains on exits: profits generated when Agronomics sells equity stake...
Agronomics Financial Statement Overview
Summary
Fundamentals are weak despite a low-risk capital structure. Income statement performance deteriorated sharply into large losses in 2024–2025, and cash flow is persistently negative (operating cash flow and free cash flow negative across all periods), implying the business has not been self-funding. The key offset is a debt-free balance sheet with a still-meaningful equity base, though equity has declined since 2023.
Income Statement
28NegativeBalance Sheet
70PositiveCash Flow
22Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -11.92M | -11.92M | -8.34M | 29.70M | 440.32K | 10.67M |
| Gross Profit | -11.92M | -11.92M | -8.34M | 29.70M | 440.32K | 10.67M |
| EBITDA | -10.05M | -32.75M | 16 | 24.57M | 1.50M | 2.46M |
| Net Income | -16.18M | -32.75M | -10.99M | 22.37M | 8.36M | 1.02M |
Balance Sheet | ||||||
| Total Assets | 140.21M | 124.67M | 157.44M | 170.20M | 146.40M | 101.65M |
| Cash, Cash Equivalents and Short-Term Investments | 2.15M | 124.62M | 12.24M | 169.87M | 146.30M | 101.21M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 234.67K | 147.60K | 166.17K | 1.95M | 2.49M | 1.62M |
| Stockholders Equity | 139.97M | 124.52M | 157.27M | 168.26M | 143.91M | 100.03M |
Cash Flow | ||||||
| Free Cash Flow | -1.24M | -1.12M | -15.86M | -23.67M | -42.21M | -12.17M |
| Operating Cash Flow | -1.24M | -1.12M | -15.86M | -23.67M | -42.21M | -12.17M |
| Investing Cash Flow | 2.28M | 1.59M | 892.00K | 10.02M | -20.02M | -11.21M |
| Financing Cash Flow | 0 | 1,714 | 1,680 | 1.01M | 31.25M | 71.82M |
Agronomics Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ANIC, the sentiment is Negative. The current price of 4.35 is below the 20-day moving average (MA) of 4.49, below the 50-day MA of 4.83, and below the 200-day MA of 5.83, indicating a bearish trend. The MACD of -0.16 indicates Negative momentum. The RSI at 37.93 is Neutral, neither overbought nor oversold. The STOCH value of 40.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ANIC.
Agronomics Peers Comparison
Overall Rating
GB:GROW70Outperform
GB:IPO61Neutral
GB:MERC61Neutral
GB:IPX58Neutral
GB:EMVC46Neutral- GB:ANIC44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| GB:GROW | 70Outperform | GBP 1.14B | 9.78 | 9.21% | ― | -78.12% | 30945.45% |
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| GB:IPO | 61Neutral | GBP 644.90M | 4.70 | 14.25% | ― | -37.29% | ― |
| GB:MERC | 61Neutral | GBP 127.84M | -15.02 | -4.78% | 3.28% | -2.25% | -350.00% |
| GB:IPX | 58Neutral | GBP 111.91M | 8.73 | 11.90% | 10.82% | -22.86% | -56.06% |
| GB:EMVC | 46Neutral | GBP 11.75M | 0.61 | 79.34% | ― | 31.28% | ― |
| GB:ANIC | 44Neutral | GBP 47.13M | -2.70 | -12.24% | ― | ― | 5.88% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:ANIC | Agronomics Limited | 4.35 | -3.65 | -45.63% | |
| GB:GROW | Molten Ventures Plc | 665.00 | 201.20 | 43.38% | |
| GB:IPX | Impax Asset Management | 92.40 | -82.03 | -47.03% | |
| GB:IPO | IP Group plc | 73.00 | 12.10 | 19.87% | |
| GB:MERC | Mercia Asset Management Plc | 30.50 | 1.53 | 5.28% | |
| GB:EMVC | NetScientific plc | 42.00 | -4.00 | -8.70% |
Agronomics Corporate Events
Agronomics Chair Jim Mellon Lifts Stake and Tightens Ties With BlueNalu
PositiveAgronomics has disclosed that executive chair Jim Mellon purchased 27,490,407 Agronomics ordinary shares from portfolio company BlueNalu for US$2 million, alongside previously unreported market purchases of 6,050,000 shares in March, lifting his tota...
Tropic Biosciences buys Rahan Meristem to build integrated banana genetics leader
PositiveAgronomics’ portfolio company Tropic Biosciences has acquired banana propagation specialist Rahan Meristem for $20 million, gaining a network of facilities across Latin America, Asia and the Middle East capable of producing more than 30 million...
Agronomics Portfolio Firm Bond Pet Foods Wins FDA Nod for Novel Fermented Pet Protein
PositiveAgronomics said portfolio company Bond Pet Foods has received a US FDA Center for Veterinary Medicine Letter of No Objection for its Lamb Protein Yeast ingredient for use in adult dog food. Developed with Hill’s Pet Nutrition, the precision-fer...
Agronomics Portfolio Firm HydGene Joins Greentown Go Make 2026 Decarbonisation Cohort
PositiveAgronomics has highlighted that portfolio company HydGene Renewables, a climate-tech firm developing modular biological systems to produce low-carbon hydrogen and industrial chemicals from waste biomass, has been chosen for Greentown Go Make 2026. Th...
Agronomics boosts SuperMeat stake with premium-funded Series A-4 investment
PositiveAgronomics has led a US$6 million initial closing of SuperMeat’s targeted US$10 million Series A-4 round, contributing US$5 million via the issue of 26,805,903 new shares at a significant premium to its recent market price, while an affiliated...
Agronomics’ Meatly Raises £10.4m to Build Europe’s Largest Cultivated Pet Food Plant
PositiveAgronomics’ portfolio company Good Dog Food, trading as Meatly, has closed a £10.4 million Series A round led by climate and consumer-focused investors, lifting its total funding to £17.5 million. Meatly, which develops cultivated mea...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jan 04, 2026